What is Organon's number of medicines and products?

Organon (OGN) reported number of medicines and products of 70 in Q1 2026.

How has Organon's number of medicines and products changed year-over-year?

Organon's number of medicines and products decreased by 0.0% year-over-year, from 70 to 70.

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Market cap$3.53B-59.4%

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Reported directly by Organon in its filing.

Tagged under the XBRL concept ogn:NumberOfMedicinesAndProducts.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

What is Organon's number of medicines and products?: Organon (OGN) reported number of medicines and products of 70 in Q1 2026.
How has Organon's number of medicines and products changed year-over-year?: Organon's number of medicines and products decreased by 0.0% year-over-year, from 70 to 70.